Literature DB >> 11003435

Conventional running suture and continuous double loop closure: an experimental study of wound strength.

Y Cengiz1, P Månsson, L A Israelsson.   

Abstract

OBJECTIVE: To study the strength of laparotomy wounds closed by a continuous double loop technique or a conventional running suture, taking into account the ratio of suture length: wound length.
DESIGN: Experimental study. ANIMALS: 60 Sprague-Dawley rats.
INTERVENTIONS: Midline laparotomy incisions were closed with either a conventional running suture or a continuous double loop. Wounds were allocated to closure with a suture length: wound length ratio of 3, 4 and 7. MAIN OUTCOME MEASURES: Bursting pressure, bursting volume and the way the suture cut through the tissues.
RESULTS: With a suture length: wound length ratio of 3 or 4 bursting pressure and bursting volume were lower with a continuous double loop closure. A conventional running suture and a continuous double loop produced similar bursting pressure and bursting volume only if closure was with a ratio of 7.
CONCLUSIONS: Wound bursting strength is higher with a conventional running suture than with a continuous double loop closure when the effect of the suture length: wound length ratio is accounted for.

Entities:  

Mesh:

Year:  2000        PMID: 11003435     DOI: 10.1080/110241500750008321

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  2 in total

1.  Long-term outcome study in patients with abdominal wound dehiscence: a comparative study on quality of life, body image, and incisional hernia.

Authors:  Gabrielle H van Ramshorst; Hasan H Eker; Jan A van der Voet; Johannes Jeekel; Johan F Lange
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

2.  New suture materials for midline laparotomy closure: an experimental study.

Authors:  Juan M Bellón; Paloma Pérez-López; Raquel Simón-Allue; Sandra Sotomayor; Bárbara Pérez-Köhler; Estefanía Peña; Gemma Pascual; Begoña Calvo
Journal:  BMC Surg       Date:  2014-09-17       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.